Key facts
- Novo Nordisk's pill reached one million prescriptions within 12 weeks of its U.S. launch.
- The drug subsequently achieved an additional two million prescriptions in the following 10 weeks.
- The total prescription milestone reached is three million.
The Danish pharmaceutical company Novo Nordisk announced that its recently launched pill has achieved significant traction in the U.S. market. The drug reached one million prescriptions within 12 weeks of its availability through U.S. pharmacies and online providers. Following this initial success, the company reported that the pill achieved an additional two million prescriptions in the subsequent 10 weeks, bringing the total to three million prescriptions.